Lattice Engines celebrates biggest quarter in its history.
We enjoyed a productive year welcoming several new portfolio companies and celebrating three successful liquidity events.
OrthAlign, Inc., a privately held U.S. based medical device company developing precision technologies, announced today that it exceeded its total 2015 sales forecasts, growing by more than 50% versus 2014. OrthAlign has exceeded sales forecasts for the past three years.
OrthAlign, Inc., a privately held U.S.-based medical device company developing precision technologies, announced today the successful completion of its limited release phase of OrthAlign Plus(R) for Total Hip Arthroplasty use in the direct anterior hip approach. The product will commercially launch at this year’s AAOS meeting in Orlando, March 2, 2016.
Randomized controlled trial to help determine best course of treatment for deadliest form of stroke.
With the launch of TheBeaconMap.com, brands, retailers, and beacon manufacturers themselves can view beacon installations across the United States. Visitors to the site can explore the interactive map and search for beacons by business name. TheBeaconMap.com represents data collected by Reveal Mobile.
Veran Medical Technologies Inc., a privately-held medical device company and leader in image-guided endobronchial and percutaneous technology for diagnosis of lung cancer and therapy delivery, was recently awarded two U.S. patents. These patents protect their revolutionary 4D respiratory tracking that allows their SPiN Thoracic Navigation System to track a patient’s respiration during a navigational bronchoscopy and/or SPiNPerc procedure.
A series of Forbes insights profiles of thought leaders changing the business landscape: Brendan Morrissey, Co-Founder and CEO, Netsertive.
Led by River Cities Capital Funds with participation from Babson Capital Management and Netsertive’s existing investors, the funding will support accelerated investments in the Company’s innovative platform, which helps brands and local businesses drive shared local digital marketing success.
AMNIOX Medical, Inc., a TissueTech, Inc., company, announced the results of A Single-Center, Retrospective Study of Cryopreserved Umbilical Cord for Wound Healing in Patients Suffering From Chronic Wounds of the Foot and Ankle, a review of the effectiveness of NEOX® Wound Allograft in treating this patient population.